Cart
sales@molnova.com
LP-211
CAS No. 1052147-86-0
LP-211 ( —— )
Catalog No. M20108 CAS No. 1052147-86-0
LP-211 is a brain penetrant selective agonist for a 5-HT7 receptor (Ki: 0.58 nM) and >300-fold selectivity over the 5-HT1A receptor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 35 | In Stock |
|
| 5MG | 58 | In Stock |
|
| 10MG | 87 | In Stock |
|
| 25MG | 170 | In Stock |
|
| 50MG | 290 | In Stock |
|
| 100MG | 462 | In Stock |
|
| 200MG | 659 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLP-211
-
NoteResearch use only not for human use.
-
Brief DescriptionLP-211 is a brain penetrant selective agonist for a 5-HT7 receptor (Ki: 0.58 nM) and >300-fold selectivity over the 5-HT1A receptor.
-
DescriptionLP-211 is a brain penetrant selective agonist for a 5-HT7 receptor (Ki: 0.58 nM) and >300-fold selectivity over the 5-HT1A receptor.
-
Synonyms——
-
PathwayEndocrinology/Hormones
-
Target5-HT Receptor
-
Recptor5-HT7;D2 receptor;5-HT1A receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1052147-86-0
-
Formula Weight466.62
-
Molecular FormulaC30H34N4O
-
Purity>98% (HPLC)
-
SolubilityDMSO: 90 mg/mL (192.87 mM)
-
SMILESO=C(CCCCCN1CCN(CC1)c1ccccc1-c1ccccc1)NCc1ccc(cc1)C#N
-
Chemical NameN-[(4-cyanophenyl)methyl]-6-[4-(2-phenylphenyl)piperazin-1-yl]hexanamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Leopoldo M et al. Structural modifications of N-(1234-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinehexanamides: influence on lipophilicity and 5-HT7 receptor activity. Part III. J Med Chem. 2008 Sep 25;51(18):5813-22.
molnova catalog
related products
-
Strictosidinic acid
Strictosidinic acid, an orally active glycoside indole monoterpene alkaloid isolated from Psychotria myriantha leaves, inhibits precursor enzymes of 5-HT biosynthesis and reduces the 5-HT levels.
-
AVN-322 free base
A highly selective, potent, BBB penetrant and orally bioavailable 5-HT6R antagonist for the treatment of neurological disorders such as AD and schizophrenia.
-
DREADD agonist 21
DREADD agonist 21 is a potent agonist of human muscarinic acetylcholine M3 receptors (EC50=1.7 nM).
